Stonepine Capital Management

Stonepine Capital Management as of June 30, 2019

Portfolio Holdings for Stonepine Capital Management

Stonepine Capital Management holds 25 positions in its portfolio as reported in the June 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ligand Pharmaceuticals In (LGND) 13.2 $19M 168k 114.15
Vanda Pharmaceuticals (VNDA) 13.0 $19M 1.3M 14.09
Amarin Corporation 12.4 $18M 931k 19.39
BioDelivery Sciences International 8.8 $13M 2.8M 4.65
Adamas Pharmaceuticals 6.1 $8.8M 1.4M 6.20
Apollo Endosurgery 5.8 $8.4M 2.6M 3.25
Neos Therapeutics 4.4 $6.4M 5.0M 1.29
Alimera Sciences 4.0 $5.7M 6.4M 0.89
Cumberland Pharmaceuticals (CPIX) 3.8 $5.6M 872k 6.37
Enanta Pharmaceuticals (ENTA) 3.8 $5.5M 66k 84.39
Iveric Bio 3.7 $5.3M 4.1M 1.30
Htg Molecular Diagnostics 3.2 $4.6M 2.8M 1.66
Opiant Pharmaceuticals 2.9 $4.2M 316k 13.25
Xoma Corp Del (XOMA) 2.8 $4.0M 270k 14.86
Aptevo Therapeutics Inc apvo 2.4 $3.5M 3.9M 0.89
Cti Biopharma 2.3 $3.4M 3.9M 0.86
Oxford Immunotec Global 2.2 $3.1M 228k 13.76
Affimed Therapeutics B V 1.4 $2.1M 716k 2.87
Foamix Pharmaceuticals 1.1 $1.5M 651k 2.38
Viveve Med 0.9 $1.3M 3.4M 0.38
Interpace Diagnostics 0.9 $1.3M 1.8M 0.72
Matinas Biopharma Holdings, In 0.4 $575k 669k 0.86
Strongbridge Bioph shs usd 0.3 $508k 162k 3.13
Noveliontherapeuti.. 0.3 $383k 491k 0.78
Motus Gi Hldgs Incorporated 0.1 $107k 35k 3.04